Corcept Therapeutics (CORT) Debt Ratio (2012 - 2017)

Corcept Therapeutics has disclosed Debt Ratio across 6 years of filings, most recently posting 0.05 for Q2 2017.

• Debt Ratio for Q2 2017 came in at 0.05, down 86.53% year-over-year; the trailing twelve-month figure through Jun 2017 was 0.05 (down 86.53% YoY), and the FY2016 annual result was 0.21, down 59.74% from the prior year.
• Debt Ratio came in at 0.05 for Q2 2017 at Corcept Therapeutics, down from 0.13 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.98 in Q4 2014 to a low of 0.05 in Q2 2017.
• The 5-year median for Debt Ratio is 0.51 (2013), against an average of 0.51.
• Across the five-year window, Debt Ratio soared 91.27% in 2014 and sank 86.53% in 2017, its largest moves.
• Corcept Therapeutics' Debt Ratio stood at 0.56 in 2013, then jumped by 76.03% to 0.98 in 2014, then plunged by 45.87% to 0.53 in 2015, then plunged by 59.74% to 0.21 in 2016, then tumbled by 75.22% to 0.05 in 2017.
• The last three Debt Ratio figures came in at 0.05 (Q2 2017), 0.13 (Q1 2017), and 0.21 (Q4 2016), per Business Quant data.